Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
0(0%)
Results Posted
133%(4 trials)
Terminated
3(43%)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_4
3
43%
Ph phase_3
2
29%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Terminated(3)

Detailed Status

Completed3
Terminated3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (33.3%)
Phase 43 (50.0%)
N/A1 (16.7%)

Trials by Status

not_yet_recruiting114%
completed343%
terminated343%

Recent Activity

0 active trials
Showing 5 of 7
terminatedphase_3

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

NCT05056727
completed

A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece

NCT06185660
completedphase_4

Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study

NCT05347693
terminatedphase_3

Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

NCT04847232
completednot_applicable

SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients

NCT06029179
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05056727Phase 3

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

Terminated
NCT06185660

A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece

Completed
NCT05347693Phase 4

Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study

Completed
NCT04847232Phase 3

Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

Terminated
NCT06029179Not Applicable

SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients

Completed
NCT06736184Phase 4

The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients

Not Yet Recruiting
NCT04997161Phase 4

Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7